This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Select Medical (SEM) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Select Medical (SEM) have what it takes to be a top stock pick for momentum investors? Let's find out.
Universal Health (UHS) to Report Q3 Results: What to Expect
by Zacks Equity Research
Universal Health's (UHS) third-quarter earnings results are likely to reflect depressed revenues and weak admissions.
Centene's (CNC) Q3 Earnings Improve Y/Y on High Revenues
by Zacks Equity Research
Centene's (CNC) third-quarter results reflect higher revenues and managed care membership.
Anthem (ANTM) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Anthem's (ANTM) third-quarter earnings results are likely to reflect elevated costs and a softness in Commercial business line.
Will Covid-Led Higher Demand Aid Teladoc's (TDOC) Q3 Earnings?
by Zacks Equity Research
A surge in demand for virtual health care services is likely to have contributed to Teladoc's (TDOC) earnings in Q3
Analysts Estimate Select Medical (SEM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Ranked Growth Stocks to Buy for September 29th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 29th
Select Medical Enters Into Joint Venture With Rush University
by Zacks Equity Research
Select Medical (SEM) forms a joint venture with Rush University to manage healthcare operations at facilities in Chicago and Northwest Indiana area.
Centene (CNC) Offers Senior Unsecured Notes Valued $2.2B
by Zacks Equity Research
Centene (CNC) exhibits prudence by issuing senior notes amid a low interest rate environment to procure funds.
Zacks.com featured highlights include: LZB, SEM, UCTT, QFIN and BERY
by Zacks Equity Research
Zacks.com featured highlights include: LZB, SEM, UCTT, QFIN and BERY
5 Must-Buy Stocks Offering High Earnings Yield
by Rimmi Singhi
The earnings potential of a stock is an important consideration while making investment decisions. This makes the earnings yield ratio a handy tool for stock selection.
Top Ranked Growth Stocks to Buy for September 21st
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 21st
Top Ranked Growth Stocks to Buy for September 17th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 17th
Here's Why You Should Retain Cigna Stock in Your Portfolio
by Zacks Equity Research
Cigna (CI) is poised for growth, given its continuous efforts to innovate solutions and growing suite of telehealth services.
What Makes Select Medical (SEM) an Attractive Investment Pick
by Zacks Equity Research
Solid operating fundamentals and rising earnings estimate make Select Medical (SEM) a lucrative stock.
UnitedHealthcare, Canopy Health Come Up With New Health Plan
by Zacks Equity Research
UnitedHealth Group's (UNH) business, UnitedHealthcare, expands collaboration with Canopy Health by rolling out a health plan for benefiting people in the Bay Area.
Top Ranked Growth Stocks to Buy for September 11th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 11th
Is Select Medical (SEM) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Magellan, Livongo's Solution to Enhance Behavioral Health
by Zacks Equity Research
Magellan (MGLN) collaborates with Livongo, which provides Magellan customers and members access to a digital self-care solution, Livongo for Behavioral Health.
Top Ranked Growth Stocks to Buy for September 9th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 9th
The Zacks Analyst Blog Highlights: HUM, SEM, UHS and FSNUY
by Zacks Equity Research
The Zacks Analyst Blog Highlights: HUM, SEM, UHS and FSNUY
Here's Why You Should Hold Magellan Stock in Your Portfolio
by Zacks Equity Research
Magellan (MGLN) continues to benefit from cost-cutting initiatives and impressive capital position.
How to Invest After the Market Selloff
by Sejuti Banerjea
Tried and tested methods always work best when you're faced with increased uncertainty and volatility.
Tenet Healthcare Offers Senior Unsecured Notes Worth $2.5B
by Zacks Equity Research
Tenet Healthcare (THC) exhibits prudence by issuing senior notes amid a low interest rate environment to procure funds.
Top Ranked Growth Stocks to Buy for September 1st
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, September 1st.